KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $747,000.

  • Twist Bioscience's Other Non-Current Liabilities rose 83.54% to $747,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $747,000, marking a year-over-year increase of 83.54%. This contributed to the annual value of $747,000 for FY2025, which is 83.54% up from last year.
  • Per Twist Bioscience's latest filing, its Other Non-Current Liabilities stood at $747,000 for FY2025, which was up 83.54% from $407,000 recorded in FY2024.
  • Over the past 5 years, Twist Bioscience's Other Non-Current Liabilities peaked at $5.1 million during FY2021, and registered a low of $60,000 during FY2022.
  • Its 3-year average for Other Non-Current Liabilities is $543,000, with a median of $475,000 in 2023.
  • In the last 5 years, Twist Bioscience's Other Non-Current Liabilities spiked by 1,343.87% in 2021 and then plummeted by 98.82% in 2022.
  • Yearly analysis of 5 years shows Twist Bioscience's Other Non-Current Liabilities stood at $5.1 million in 2021, then crashed by 98.82% to $60,000 in 2022, then skyrocketed by 691.67% to $475,000 in 2023, then declined by 14.32% to $407,000 in 2024, then spiked by 83.54% to $747,000 in 2025.